Professor Richard DiMarchi’s work in peptide-based therapeutics has influenced a wave of groundbreaking treatments, laying the foundation for the first GLP-1 medicines, which are widely recognized under brand names such as ‘Ozempic’, 'Mounjaro', and more. Following a highly successful career across industry and academia, Professor DiMarchi became a co-recipient of the 2024 Tu Youyou Award earlier this year. Learn more about Prof. DiMarchi’s esteemed career: https://brnw.ch/21wXI0X #MDPI #OpenAccess #TuYouyouAward #ScientificExcellence
